Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Aptevo Therapeutics (APVO) Shares Outstanding (2016 - 2025)

Aptevo Therapeutics (APVO) has disclosed Shares Outstanding for 10 consecutive years, with $13.8 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding rose 59839.95% to $13.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.8 million through Sep 2025, up 59839.95% year-over-year, with the annual reading at $4051.0 for FY2024, 12175.76% up from the prior year.
  • Shares Outstanding hit $13.8 million in Q3 2025 for Aptevo Therapeutics, up from $3.2 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $13.8 million in Q3 2025 to a low of $33.0 in Q4 2023.
  • Historically, Shares Outstanding has averaged $2.7 million across 5 years, with a median of $328763.0 in 2023.
  • Biggest five-year swings in Shares Outstanding: crashed 99.92% in 2022 and later soared 59839.95% in 2025.
  • Year by year, Shares Outstanding stood at $4.9 million in 2021, then plummeted by 99.92% to $3971.0 in 2022, then tumbled by 99.17% to $33.0 in 2023, then skyrocketed by 12175.76% to $4051.0 in 2024, then skyrocketed by 340777.96% to $13.8 million in 2025.
  • Business Quant data shows Shares Outstanding for APVO at $13.8 million in Q3 2025, $3.2 million in Q2 2025, and $72925.0 in Q1 2025.